Further, insulin-resistant apoE-deficient (apoE−/−) mice on an HFD spontaneously develop PAH [31] and recently HFD-apoE−/− mice treated with a dual ETA/ETB receptor antagonist were characterized by beneficial effects on PAH [34]. Here, APOE is linked to pulmonary arterial hypertension.